The European Cardiology Society believes that vaccines against covid, flu or even zona have an interest that goes beyond the protection of specific infections: it also makes it possible to prevent cardiovascular disease.
Vacciner can protect cardiovascular disease: this is the conclusion of a scientific literature review published on June 30 in the European Heart Journal medical journal.
Vaccine against covid but also flu, zona, pneumococcus … The study, based on cohorts of thousands of patients, makes a conclusion surprising: “Vaccination is increasingly recognized as an effective preventive measure, not only against specific infections, but also for the prevention of cardiovascular disease in high -risk patients”establishes this declaration of consensus in which François Roubille, cardiologist at the CHU de Montpellier participated.
According to the investigation, “An increasing number of data suggests that influenza vaccines, SARS-COV-2, syncytial respiratory virus, zona and other viruses significantly reduce infections, and in the case of flu, major unwanted cardiovascular events in vaccinated people”.
The study recalls that 64 million people suffer from heart failure and “mace”, major unwanted unwanted cardiovascular events. And that cardiovascular diseases are a major cause of mortality.
“It’s not a surprise”
“It is not a surprise for the profession”explains François Roubille. “There are already recommendations in this sense, we hope they will be extended after this study”indicates the doctor, who also hopes that the study “will correct false ideas on vaccination”.
Despite an increase in the risk of myocarditis during a vaccination against covid? The undesirable effect is “Confirmed but infrequent and favorable evolution”established the ANSM, the drug safety agency, in 2022, and each new study confirms the analysis.
“It is a secondary problem that parasites the debate, and which only concerns the COVVID vaccine”estimates the RABILLE. Experts do not evacuate the subject, and explicitly refer to the increased risk of myocarditis. “Vaccination is a crucial subject in the development of policies and health strategies, and it arouses lively debates in public space, in particular from the Pandemic of Covid 19”, they write.
The study is not satisfied with a “Clinical consensus declaration”, south the base of “Existing literature and accumulated evidence”.
Elle “Provides practical advice at the time of vaccination and target populations”. Elle “Also includes recommendations for vaccination of vulnerable populations such as immunocompromised people, patients with congenital heart disease, pregnant women, as well as an analysis of safety aspects and potential complications of the procedure”.
“Bacterial and viral infections increase the risk of major unwanted cardiovascular event”
How to explain this beneficial effect of vaccination? “Bacterial and viral infections increase the risk of” major unwanted cardiovascular event “, recall the experts. Particularly: “Flu increases the risk of cardiopathy by 3.9 %”.
So on the flu, especially: “Vaccination reduces the risk of viral infection by 60 %, and significantly reduces the risk of complication after an infection”. “Vaccinated patients see the risk of major cardiovascular accident by 30 %.”
“The flu vaccine is recommended each year for patients with cardiovascular disease, including chronic coronary syndromes and heart failure”, they conclude.
He is “Recommended within 72 hours of a myocardial infarction, including in the event of hospitalization”.
On the influenza alone, specialists support their conclusions on the basis of hundreds of thousands of patients included in trials.
The zona vaccine is “Recommended, especially in the elderly or immunocompromised, with a cardiovascular protective effect estimated at more than 50 %”.
For the syncytial respiratory virus vaccine, the prospects are promising: “It is 89 % effective in the elderly against respiratory infections. Cardiovascular data is promising but still limited “establishes the college of doctors.
